Hosted by:
10:30 | ![]()
|
10:40 | ![]()
|
10:50 | ![]()
|
11:00 | ![]()
|
11:10 | ![]()
|
11:20 | ![]()
|
11:30 | ![]()
|
11:40 | ![]()
|
11:50 | ![]()
|
12:00 |
Seeding Change: Challenges and Opportunities for Medtech and Healthtech Spin-Out Funding Medtech and Healthtech spin-outs seeking seed funding face a variety of obstacles in the current funding climate. Yet, with their academic expertise, cutting-edge research, and transformative technologies, there is an abundance of potential growth and innovation opportunities to help shape the healthcare industry. A panel of investors discuss how spin-outs can avoid getting stuck at the first hurdles.
Marion Bernard, Chief Investment Officer, Northern Gritstone Erki Mölder, Managing Partner, Verge HealthTech Fund Rebecca Todd, Investment Director, Longwall Venture Partners
|
12:40 | ![]()
|
12:50 | ![]()
|
13:00 | ![]()
|
13:10 |
|
13:20 |
|
13:30 |
|
13:40 |
|
13:50 | ![]()
|
14:00 |
|
14:10 | ![]()
|
14:20 | ![]()
|
14:30 |
Pharma Collaborations: Failures to Successes Within the scope of this overarching theme, we have the opportunity to delve into a multitude of subjects, including:
Moderated: Anne Horgan, Partner, Cambridge Innovation Capital
|
15:00 | ![]()
|
15:10 | ![]()
|
15:20 |
|
15:30 |
|
15:40 |
|
15:50 |
|
16:00 |
|
16:10 |
|
16:20 |
|
16:30 |
|
17:00 |
Drinks Reception |
18:00 |
Close of Investival Showcase |
18:30 |
Awards & Gala Dinner |
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd